Clinical trials for BRCA positive breast cancer


Trial name


Title of clinical trial






A trial to see if taking olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2 negative primary breast cancer reduces the risk of breast cancer coming back after finishing standard treatment.
Open to men & women.


Clinical Trials Information